What is the ticker symbol for Immuneering?

Immuneering trades under the ticker IMRX on NASDAQ.

What sector does Immuneering operate in?

Immuneering is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMRX in a portfolio?

PortView shows IMRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Immuneering (IMRX) Stock Analysis

NASDAQHealthcareBiotechnology

$4.81-0.66%

1-year price historyRange $3.92 – $9.26

52-week range$4.81

$3.86$10.08

What Immuneering does

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS and/or RAF gene mutations. The second is IMM-6-415, which is being developed to treat solid tumors. Beyond these advanced-stage programs, Immuneering's early-stage pipeline includes five oncology initiatives aimed at components of the MAPK or mTOR signaling pathways, along with two neuroscience programs, all currently in the discovery phase. Founded in 2008, Immuneering Corporation is headquartered in Cambridge, Massachusetts. It was formerly a subsidiary of Teva Pharmaceutical Industries Limited.

Key metrics

Market cap

$174.72M

P/E (TTM)

-4.63

EPS (TTM)

$-1.04

Beta

0.37

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$4.82

200-day avg

$5.28

52-week high

$10.08

52-week low

$3.86

CEO

Benjamin J. Zeskind

ETFs linked to IMRX

Broad-market and Healthcare sector ETFs an investor holding Immuneering is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IMRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Immuneering?: Immuneering trades under the ticker IMRX on NASDAQ.
Which exchange is IMRX listed on?: IMRX is listed on NASDAQ.
What sector does Immuneering operate in?: Immuneering is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMRX in a portfolio?: PortView shows IMRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.